International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report)’s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.08 and traded as high as $0.12. International Stem Cell shares last traded at $0.12, with a volume of 5,012 shares changing hands.
International Stem Cell Stock Performance
The stock has a market capitalization of $930,400.00, a P/E ratio of -1.45 and a beta of 0.30. The company’s fifty day simple moving average is $0.10 and its two-hundred day simple moving average is $0.08.
International Stem Cell Company Profile
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Featured Articles
- Five stocks we like better than International Stem Cell
- What is Short Interest? How to Use It
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Inflation Persists, But So Do Stock Opportunities: Rally On
- How to buy stock: A step-by-step guide for beginners
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
